HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
500.31
-2.69 (-0.53%)
At close: Dec 2, 2025, 4:00 PM EST
500.17
-0.14 (-0.03%)
After-hours: Dec 2, 2025, 7:27 PM EST
HCA Healthcare Stock Forecast
Stock Price Forecast
The 18 analysts that cover HCA Healthcare stock have a consensus rating of "Buy" and an average price target of $463.06, which forecasts a -7.45% decrease in the stock price over the next year. The lowest target is $370 and the highest is $525.
Price Target: $463.06 (-7.45%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 2 | 2 | 2 | 6 | 5 |
| Buy | 6 | 6 | 6 | 6 | 7 | 7 |
| Hold | 6 | 8 | 8 | 9 | 9 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 17 | 22 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $412 → $431 | Hold | Maintains | $412 → $431 | -13.85% | Nov 13, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $485 → $525 | Strong Buy | Maintains | $485 → $525 | +4.93% | Oct 28, 2025 |
| UBS | UBS | Strong Buy Maintains $495 → $525 | Strong Buy | Maintains | $495 → $525 | +4.93% | Oct 27, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $430 → $470 | Hold | Maintains | $430 → $470 | -6.06% | Oct 27, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $470 → $520 | Strong Buy | Maintains | $470 → $520 | +3.94% | Oct 27, 2025 |
Financial Forecast
Revenue This Year
76.53B
from 70.60B
Increased by 8.39%
Revenue Next Year
80.01B
from 76.53B
Increased by 4.55%
EPS This Year
27.86
from 22.00
Increased by 26.65%
EPS Next Year
30.03
from 27.86
Increased by 7.76%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 79.9B | 84.6B | ||||
| Avg | 76.5B | 80.0B | ||||
| Low | 73.8B | 75.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 13.2% | 10.6% | ||||
| Avg | 8.4% | 4.5% | ||||
| Low | 4.6% | -1.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 29.63 | 32.99 | ||||
| Avg | 27.86 | 30.03 | ||||
| Low | 25.92 | 26.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 34.7% | 18.4% | ||||
| Avg | 26.7% | 7.8% | ||||
| Low | 17.8% | -4.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.